Translational Research · Project detail
PERAMEDIC, Horizon Europe
A Horizon Europe project developing a stand-alone system for individually customised, segmented-release polypills in personal adaptive medicine.
01 · Project facts
Personalised formulation designed around individual therapeutic needs.
PERAMEDIC is developing a stand-alone drug formulation system for locally prepared, individually customised, segmented-release polypills. Its published technology approach combines personal release profiles, in-situ 3D printing of a release matrix and multichannel powder dosing into sealed microcompartments.
02 · Assignment
Turning a personal-adaptive concept into a coherent technology pathway.
The project frames a tabletop pill and capsule printing system around individual dose quantities and release distributions, with clinical settings, pharmacies and medical practices described as future application scenarios.
Release profilesIndividually customised segmented-release formulation.
Matrix printingIn-situ 3D printing with adaptive toolpaths.
Powder dosingMultichannel dosing into sealed microcompartments.
03 · Project context
A technical concept addressing practical formulation constraints.
PersonalisationA single daily pill can combine medication and supplements with individual quantities and release distributions.
Development pathThe first stage is a lab-scale proof-of-concept of the combined novel technologies.
Application horizonClinical settings first, with pharmacy and medical-practice scenarios described for later stages.
Field note
Individual dosing becomes a credible innovation pathway when formulation, delivery and use settings are considered together.
PM
04 · Programme context & related projects
A Horizon Europe research and innovation assignment.
The project has received funding from the European Union’s Horizon Europe Research and Innovation Programme under grant agreement 101130241. Explore related Translational Research assignments below.